文献速递药物相互作用药物不良反应与药物警戒

高剂量伊维菌素联合双氢青蒿素哌喹的PK/PD:杀蚊活性与QT间期延长

Pharmacokinetics-Pharmacodynamics of High-Dose Ivermectin with Dihydroartemisinin-Piperaquine on Mosquitocidal Activity and QT-Prolongation (IVERMAL).
PubMed 文献 · Clin Pharmacol Ther · 2018-10-09

在肯尼亚141例无并发症疟疾成人中,随机给予3天伊维菌素0、300或600 mcg/kg/天联合DP,采集静脉和毛细血管血浆样本、蚊群死亡率及QTcF间期数据。PK/PD模型显示预测伊维菌素浓度与观察到的杀蚊效应在28天内一致相关,伊维菌素不影响哌喹PK或QTcF延长。

要点

  • 伊维菌素血药浓度与杀蚊效应在28天内一致相关,无需假设未知代谢物或药物相互作用。
  • 伊维菌素对哌喹的药代动力学和QTcF延长无影响。
  • PK/PD模型可用于设计具有预测杀蚊效应的新治疗方案。

核心结论

  • 预测伊维菌素浓度与观察到的杀蚊效应在28天研究期间一致相关,且伊维菌素对哌喹PK和QTcF延长无影响。

研究设计与样本

  • 在肯尼亚141例无并发症疟疾成人中随机分配3天伊维菌素0、300或600 mcg/kg/天联合DP。
  • 随访28天,收集1393份静脉和335份配对毛细血管血浆样本、850个蚊群死亡率及524个QTcF间期。

主要发现

  • PK/PD模型显示预测伊维菌素浓度与观察杀蚊效应在整个28天研究期间一致相关。
  • 无需引入未知杀蚊代谢物或药物相互作用即可解释观察到的杀蚊效应。
  • 伊维菌素对哌喹的药代动力学无影响。
  • 伊维菌素对QTcF延长无影响。

临床怎么用

  • PK/PD模型可用于设计新的治疗方案并预测杀蚊效应。
  • 该方法学可用于评估其他内吸杀虫剂的有效性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

High-dose ivermectin, co-administered for 3 days with dihydroartemisinin-piperaquine (DP), killed mosquitoes feeding on individuals for at least 28 days posttreatment in a recent trial (IVERMAL), whereas 7 days was predicted pretrial. The current study assessed the relationship between ivermectin blood concentrations and the observed mosquitocidal effects against Anopheles gambiae s.s. Three days of ivermectin 0, 300, or 600 mcg/kg/day plus DP was randomly assigned to 141 adults with uncomplicated malaria in Kenya. During 28 days of follow-up, 1,393 venous and 335 paired capillary plasma samples, 850 mosquito-cluster mortality rates, and 524 QTcF-intervals were collected. Using pharmacokinetic/pharmacodynamic (PK/PD) modeling, we show a consistent correlation between predicted ivermectin concentrations and observed mosquitocidal-effects throughout the 28-day study duration, without invoking an unidentified mosquitocidal metabolite or drug-drug interaction. Ivermectin had no effect on piperaquine's PKs or QTcF-prolongation. The PK/PD model can be used to design new treatment regimens with predicted mosquitocidal effect. This methodology could be used to evaluate effectiveness of other endectocides.

来源:Clin Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Smit MR, Ochomo EO, Waterhouse D, et al. Pharmacokinetics-Pharmacodynamics of High-Dose Ivermectin with Dihydroartemisinin-Piperaquine on Mosquitocidal Activity and QT-Prolongation (IVERMAL). Clin Pharmacol Ther. 2018. PMID: 30125353. doi:10.1002/cpt.1219

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。